Search Results - "Clinical and applied thrombosis/hemostasis"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    COVID-19 and Hypercoagulability: A Review by Kichloo, Asim, Dettloff, Kirk, Aljadah, Michael, Albosta, Michael, Jamal, Shakeel, Singh, Jagmeet, Wani, Farah, Kumar, Akshay, Vallabhaneni, Srilakshmi, Khan, Muhammad Zia

    “…Thrombotic complications of the novel coronavirus (COVID-19) are a concerning aspect of the disease, due to the high incidence in critically ill patients and…”
    Get full text
    Book Review Journal Article
  5. 5

    Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis by Chang, Jae C.

    “…Acute respiratory distress syndrome (ARDS) is a life-threatening noncardiogenic circulatory disorder of the lungs associated with critical illnesses such as…”
    Get full text
    Book Review Journal Article
  6. 6

    Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation by Canpolat, Ugur, Çetin, Elif Hande, Cetin, Serkan, Aydin, Selahattin, Akboga, Mehmet Kadri, Yayla, Cagri, Turak, Osman, Aras, Dursun, Aydogdu, Sinan

    Published in Clinical and applied thrombosis/hemostasis (01-07-2016)
    “…Previous studies proposed that both inflammation, oxidative stress, and impaired endothelial dysfunction have a significant role in occurrence of slow coronary…”
    Get more information
    Journal Article
  7. 7

    Oral Contraceptives and HRT Risk of Thrombosis by Gialeraki, Argyri, Valsami, Serena, Pittaras, Theodoros, Panayiotakopoulos, George, Politou, Marianna

    Published in Clinical and Applied Thrombosis/Hemostasis (01-03-2018)
    “…Estrogen-containing medication, prescribed either for contraception in women of reproductive age or for prevention of cardiovascular events and osteoporosis as…”
    Get full text
    Book Review Journal Article
  8. 8

    COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response by Jayarangaiah, Apoorva, Kariyanna, Pramod Theetha, Chen, Xiaoyi, Jayarangaiah, Amog, Kumar, Abhishek

    “…Since the onset of the global pandemic in early 2020, coronavirus disease 2019 (COVID-19) has posed a multitude of challenges to health care systems worldwide…”
    Get full text
    Book Review Journal Article
  9. 9

    Viral Coagulopathy in Patients With COVID-19: Treatment and Care by Kipshidze, Nickolas, Dangas, George, White, Christopher J., Kipshidze, Nodar, Siddiqui, Fakiha, Lattimer, Christopher R., Carter, Charles A., Fareed, Jawed

    “…COVID-19 has proven to be particularly challenging given the complex pathogenesis of SARS-CoV-2. Early data have demonstrated how the host response to this…”
    Get full text
    Book Review Journal Article
  10. 10

    COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation by Miesbach, Wolfgang, Makris, Michael

    “…The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can…”
    Get full text
    Book Review Journal Article
  11. 11

    Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan by Chen, Jianpu, Wang, Xiang, Zhang, Shutong, Lin, Bin, Wu, Xiaoqing, Wang, Yanfang, Wang, Xiaoqi, Yang, Ming, Sun, Jianqing, Xie, Yuanliang

    “…The aim of this study was to describe clinical, imaging, and laboratory features of acute pulmonary embolism (APE) in patients with COVID-19 associated…”
    Get full text
    Journal Article
  12. 12

    Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19 by Xia, Wei, Tan, Yafeng, Hu, Shengmei, Li, Chengbin, Jiang, Tao

    Published in Clinical and applied thrombosis/hemostasis (01-06-2022)
    “…Objective: It was initially reported that a novel coronavirus (COVID-19) had been identified in Wuhan, China, in December 2019.To date, COVID-19 is still…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Incidence and Risk Factors of Deep Vein Thrombosis in Patients With Pelvic and Acetabular Fractures by Wang, Pengfei, Kandemir, Utku, Zhang, Binfei, Wang, Baohui, Li, Jiahao, Zhuang, Yan, Wang, Hu, Zhang, Hong, Liu, Ping, Zhang, Kun

    Published in Clinical and applied thrombosis/hemostasis (01-01-2019)
    “…This study aimed to investigate the incidence and risk factors for deep vein thrombosis (DVT) in patients with pelvic and acetabular fractures. Patients with…”
    Get full text
    Journal Article
  15. 15

    The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System by Arreola-Diaz, R, Majluf-Cruz, A, Sanchez-Torres, LE, Hernandez-Juarez, J

    Published in Clinical and Applied Thrombosis/Hemostasis (01-03-2022)
    “…The antiphospholipid syndrome (APS), a systemic autoimmune disease characterized by a hypercoagulability associated to vascular thrombosis and/or obstetric…”
    Get full text
    Book Review Journal Article
  16. 16

    Comparison of Venous Thrombosis Complications in Midlines Versus Peripherally Inserted Central Catheters: Are Midlines the Safer Option? by Bahl, Amit, Karabon, Patrick, Chu, David

    Published in Clinical and applied thrombosis/hemostasis (01-01-2019)
    “…Catheter-related (CR) thrombosis is a significant complication of midline catheters (MCs) and peripherally inserted central catheters (PICCs). Limited existing…”
    Get full text
    Journal Article
  17. 17

    Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome by Buyukkaya, Eyup, Karakas, Mehmet Fatih, Karakas, Esra, Akçay, Adnan Burak, Tanboga, Ibrahim Halil, Kurt, Mustafa, Sen, Nihat

    Published in Clinical and applied thrombosis/hemostasis (01-03-2014)
    “…The aim of this study is to investigate the relationship between the criteria comprising metabolic syndrome (MS) and neutrophil-lymphocyte ratio (NLR), a…”
    Get more information
    Journal Article
  18. 18

    Comparison of the Long-Term Remission of Rituximab and Conventional Treatment for Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis by Owattanapanich, Weerapat, Wongprasert, Chompunut, Rotchanapanya, Wannaphorn, Owattanapanich, Natthida, Ruchutrakool, Theera

    Published in Clinical and applied thrombosis/hemostasis (01-01-2019)
    “…The current systematic review and meta-analysis aimed to summarize the results of all available studies to compare the efficacies of rituximab and conventional…”
    Get full text
    Journal Article
  19. 19

    Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism by Phan, Trung, Brailovsky, Yevgeniy, Fareed, Jawed, Hoppensteadt, Debra, Iqbal, Omer, Darki, Amir

    “…The aim of this study was to investigate the utility of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) to predict all-cause…”
    Get full text
    Journal Article
  20. 20

    Implementation and Validation of the 2013 Caprini Score for Risk Stratification of Arthroplasty Patients in the Prevention of Venous Thrombosis by Krauss, Eugene S., Segal, Ayal, Cronin, MaryAnne, Dengler, Nancy, Lesser, Martin L., Ahn, Seungjun, Caprini, Joseph A.

    Published in Clinical and applied thrombosis/hemostasis (03-04-2019)
    “…Appropriate chemoprophylaxis choice following arthroplasty requires accurate patient risk assessment. We compared the results of our prospective department…”
    Get full text
    Journal Article